Bausch Health Companies (BHC) Total Current Liabilities (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Total Current Liabilities came in at $4.5 billion in Q1 2026, up 6.44% year-on-year from $4.3 billion in Q1 2025, and up 8.37% quarter-over-quarter from $4.2 billion in Q4 2025.
Bausch Health Companies (BHC) Total Current Liabilities (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Total Current Liabilities across 18 years of filings, most recently posting $4.5 billion for Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $4.5 billion, up 6.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.5 billion (up 6.44% YoY), and the FY2025 annual result was $4.2 billion, down 38.09% from the prior year.
- Total Current Liabilities came in at $4.5 billion for Q1 2026 at Bausch Health Companies, up from $4.2 billion in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $6.8 billion in Q4 2024 to a low of $3.8 billion in Q3 2022.
- The 5-year median for Total Current Liabilities is $4.4 billion (2024), against an average of $4.5 billion.
- Across the five-year window, Total Current Liabilities surged 56.95% in 2024 and sank 38.09% in 2025, its largest moves.
- Bausch Health Companies' Total Current Liabilities stood at $3.9 billion in 2022, then increased by 9.16% to $4.3 billion in 2023, then soared by 56.95% to $6.8 billion in 2024, then tumbled by 38.09% to $4.2 billion in 2025, then rose by 8.37% to $4.5 billion in 2026.
- The last three Total Current Liabilities figures came in at $4.5 billion (Q1 2026), $4.2 billion (Q4 2025), and $4.8 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | Bausch Health Companies | 1.93 Bn | 1.59 Bn | 2.48 Bn | 4.53 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.53 Bn |
| Dec 31, 2025 | 4.18 Bn |
| Sep 30, 2025 | 4.79 Bn |
| Jun 30, 2025 | 4.98 Bn |
| Mar 31, 2025 | 4.26 Bn |
| Dec 31, 2024 | 6.75 Bn |
| Sep 30, 2024 | 4.51 Bn |
| Jun 30, 2024 | 4.37 Bn |
| Mar 31, 2024 | 4.41 Bn |
| Dec 31, 2023 | 4.30 Bn |
| Sep 30, 2023 | 4.22 Bn |
| Jun 30, 2023 | 3.97 Bn |
| Mar 31, 2023 | 3.92 Bn |
| Dec 31, 2022 | 3.94 Bn |
| Sep 30, 2022 | 3.83 Bn |
| Jun 30, 2022 | 5.00 Bn |
| Mar 31, 2022 | 4.77 Bn |
| Dec 31, 2021 | 5.20 Bn |
| Sep 30, 2021 | 5.44 Bn |
| Jun 30, 2021 | 5.52 Bn |